Join
Live feed
·
INSIDERFilingvia Quantisnow
Channel Therapeutics Corporation logo

Director Davis Todd C converted options into 1,500,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CHRO· Channel Therapeutics Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CHRO (Channel Therapeutics Corporation) and more on Quantisnow.